Xilio Therapeutics, Inc.
US ˙ NasdaqGS ˙ US98422T1007

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Timothy P Clackson. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Timothy P Clackson har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ELEV / Elevation Oncology, Inc. Director 0
US: / THESEUS PHARMACEUTICALS INC President and CEO, Director 351.030
US:FMTX / Forma Therapeutics Holdings Inc Director 0
US:XLO / Xilio Therapeutics, Inc. 10% Owner 20.068
US:849CVR014 / CVR F STAR Director 50.486
US:ARIA / ARIAD Pharmaceuticals, Inc. President, R&D, CSO 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Timothy P Clackson. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb XLO / Xilio Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i XLO / Xilio Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XLO / Xilio Therapeutics, Inc. Insider Trades
Insidersalg XLO / Xilio Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i XLO / Xilio Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XLO / Xilio Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Timothy P Clackson som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-24 2025-07-23 4 ELEV Elevation Oncology, Inc.
Common Stock
U - Other -47.330 0 -100,00 0,36 -17.039
2023-09-05 2023-09-01 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -15.777 0 -100,00
2022-11-14 2022-11-11 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.500 351.030 0,72 6,80 16.995 2.386.302
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -7.250 0 -100,00
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -23.590 0 -100,00
2022-06-22 2022-05-31 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -31.553 15.777 -66,67
2022-06-09 2022-06-08 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 4.500 30.840 17,08
2022-02-23 2022-02-18 4 THRX Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 450.000 450.000
2021-12-22 2021-12-21 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.600 348.530 0,75 9,76 25.381 3.402.385
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
20.068
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
70.888
2021-10-06 3 THRX Theseus Pharmaceuticals, Inc.
Common Stock
345.930
2021-06-24 3 ELEV Elevation Oncology, Inc.
Common Stock
47.330
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 8.375 8.375
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 2.750 26.340 11,66
2020-10-01 2020-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 9.422 50.486 22,94
2020-07-01 2020-06-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 8.588 41.064 26,44
2020-06-25 2020-06-24 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
S - Sale -35.067 0 -100,00
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Common Stock
P - Purchase 23.590 23.590
2020-06-22 2020-06-18 4 FMTX Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy)
A - Award 17.533 0 -100,00
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43.144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43.144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43.144
2020-04-01 2020-03-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 13.575 32.476 71,82
2020-01-02 2019-12-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 7.991 18.901 73,24
2019-10-01 2019-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3.670 10.910 50,69
2019-07-11 2019-07-10 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2019-07-01 2019-06-28 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3.421 7.240 89,58
2019-04-02 2019-03-29 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1.204 3.819 46,04
2019-01-03 2019-01-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1.083 2.615 70,69
2018-10-02 2018-10-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 788 1.532 105,91
2018-07-03 2018-07-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 744 744
2018-03-05 2018-03-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 11.000 11.000
2018-03-05 3 SBPH Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned
0
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -14.550 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -72.980 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -87.125 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -65.000 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -82.000 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -577 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -219.867 0 -100,00
2017-02-07 2017-02-06 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 14.550 14.550
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29.333 0 -100,00
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -9.610 219.867 -4,19 23,82 -228.886 5.236.682
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29.333 229.477 14,66
2016-10-25 2016-10-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19.638 197.884 -9,03 9,56 -187.739 1.891.771
2016-09-28 2016-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8.750 217.522 -3,87 13,98 -122.311 3.040.610
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17.500 0 -100,00
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17.500 226.272 8,38
2016-09-23 2016-09-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 208.772 -8,74 13,43 -268.536 2.803.140
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -59.369 0 -100,00
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -59.369 228.772 -20,60 11,73 -696.398 2.683.496
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 59.369 288.141 25,95 7,82 464.266 2.253.263
2016-08-23 2016-08-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19.436 228.772 -7,83 10,47 -203.538 2.395.746
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25.000 0 -100,00
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -25.000 248.208 -9,15 10,50 -262.500 2.606.184
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 25.000 273.208 10,07 7,69 192.250 2.100.970
2016-07-25 2016-07-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -18.286 248.208 -6,86 8,11 -148.230 2.012.024
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30.000 0 -100,00 3,25 -97.500
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -31.422 0 -100,00 4,49 -141.085
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -30.000 266.494 -10,12 7,48 -224.481 1.994.095
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 30.000 296.494 11,26 3,25 97.500 963.606
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31.422 266.494 -10,55 7,48 -235.153 1.994.361
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 31.422 297.916 11,79 4,49 141.085 1.337.643
2016-06-23 2016-06-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23.999 264.742 -8,31 7,28 -174.638 1.926.501
2016-05-25 2016-05-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -17.762 288.741 -5,80 8,08 -143.430 2.331.612
2016-05-02 2016-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -11.700 306.503 -3,68 7,13 -83.478 2.186.868
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -23.400 0 -100,00
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23.400 318.203 7,94
2016-04-25 2016-04-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -21.409 294.803 -6,77 7,37 -157.864 2.173.789
2016-03-23 2016-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23.834 316.212 -7,01 6,58 -156.871 2.081.244
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10.833 0 -100,00
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5.417 340.046 -1,57 6,47 -35.039 2.199.520
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.833 345.463 3,24
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 26.180 26.180
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 87.125 87.125
2016-03-03 2016-03-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9.625 334.630 -2,80 6,12 -58.867 2.046.631
2016-03-03 2016-03-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -25.047 344.255 -6,78 6,00 -150.282 2.065.530
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 38.500 38.500
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -19.250 19.250 -50,00
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19.250 369.302 5,50
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29.333 29.333 -50,00
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14.667 350.052 -4,02 4,81 -70.517 1.683.015
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29.333 364.719 8,75
2015-09-28 2015-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8.750 334.086 -2,55 6,46 -56.560 2.159.532
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 35.000 35.000
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17.500 17.500 -50,00
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17.500 342.836 5,38
2015-07-16 2015-07-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7.000 325.336 -2,11 8,54 -59.797 2.779.150
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14.000 0 -100,00
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14.000 332.336 4,40
2015-04-30 2015-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 70.200 70.200
2015-04-27 2015-04-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -123.766 316.548 -28,11 9,50 -1.175.777 3.007.206
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.333 0 -100,00
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6.667 440.314 -1,49 8,55 -57.016 3.765.565
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.333 446.981 3,07
2015-03-23 2015-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5.417 433.648 -1,23 8,84 -47.910 3.835.313
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.657 0 -100,00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10.833 10.833 -50,00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -20.657 440.314 -4,48 9,00 -185.913 3.962.826
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20.657 460.971 4,69 7,56 156.167 3.484.941
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.833 439.065 2,53
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24.036 31.422 -43,34
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24.999 0 -100,00
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24.036 428.232 -5,31 8,00 -192.288 3.425.856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24.036 452.268 5,61 4,49 107.922 2.030.683
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24.999 428.232 -5,52 8,00 -199.992 3.425.856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24.999 453.231 5,84 2,62 65.497 1.187.465
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29.334 58.666 -33,33
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14.667 428.232 -3,31 6,33 -92.820 2.710.066
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29.334 442.899 7,09
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14.000 14.000 -50,00
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -4.564 413.565 -1,09 5,57 -25.421 2.303.557
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14.000 418.129 3,46
2014-04-03 2014-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6.500 403.028 -1,59 8,21 -53.337 3.307.127
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.000 0 -100,00
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.000 409.528 3,28
2014-03-21 2014-03-21 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6.667 394.377 -1,66 7,89 -52.583 3.110.451
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.333 13.333 -50,00
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.333 401.044 3,44
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10.834 21.666 -33,34
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -3.442 387.711 -0,88 8,19 -28.190 3.175.353
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.834 391.153 2,85
2014-02-04 2014-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 88.000 88.000
2013-12-20 2013-12-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9.750 380.319 -2,50 5,14 -50.115 1.954.840
2013-12-20 2013-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19.500 390.069 5,26
2013-09-10 2013-09-06 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8.449 370.451 -2,23 22,00 -185.878 8.149.922
2013-07-18 2013-07-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14.000 378.900 -3,56 19,79 -277.045 7.498.014
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -28.000 28.000 -50,00
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 56.000 56.000
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 28.000 392.900 7,67
2013-04-03 2013-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6.500 363.705 -1,76 18,04 -117.245 6.560.402
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.000 0 -100,00
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.000 370.205 3,64
2013-03-26 2013-03-25 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -19.167 357.205 -5,09 18,87 -361.766 6.742.030
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38.333 0 -100,00
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38.333 376.372 11,34
2013-03-22 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6.667 338.039 -1,93 19,46 -129.718 6.577.123
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.334 0 -100,00
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.334 344.706 4,02
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 65.000 65.000
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 32.500 32.500
2013-03-05 2013-03-04 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9.838 331.372 -2,88 21,00 -206.598 6.958.812
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8.631 17.262 -33,33
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -44.542 0 -100,00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -4.766 0 -100,00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8.631 341.210 2,60 7,82 67.494 2.668.262
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 44.542 332.579 15,46 4,49 199.994 1.493.280
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 4.766 288.037 1,68 5,23 24.926 1.506.434
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -27.000 4.766 -85,00
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 27.000 282.940 10,55 5,23 141.210 1.479.776
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -8.142 255.940 -3,08 20,18 -164.306 5.164.869
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19.500 264.082 7,97
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -1 24.999 0,00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -10.000 30.000 -25,00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 1 244.170 0,00 2,62 3 639.725
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 244.169 4,27 3,25 32.500 793.549
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -36.843 0 -100,00
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -36.843 234.169 -13,59 20,00 -736.860 4.683.380
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 36.843 271.012 15,73 7,56 278.533 2.048.851
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -23.234 31.766 -42,24
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23.234 234.169 -9,03 19,00 -441.446 4.449.211
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23.234 257.403 9,92 5,23 121.514 1.346.218
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 233.778 -7,88 17,00 -340.000 3.974.226
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 253.778 8,56 7,44 148.800 1.888.108
2012-04-17 2012-04-17 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7.111 233.778 -2,95 15,00 -106.665 3.506.670
2012-04-17 2012-04-13 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31.600 240.889 -11,60 14,83 -468.628 3.572.384
2012-04-03 2012-04-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5.200 272.489 -1,87 16,18 -84.134 4.408.763
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.000 26.000 -33,33
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.000 277.689 4,91
2012-04-03 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -26.061 264.689 -8,96 16,34 -425.876 4.325.415
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -7.500 0 -100,00
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7.500 290.750 -2,51 16,00 -120.000 4.652.000
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 7.500 298.250 2,58 6,39 47.925 1.905.818
2012-03-26 2012-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -15.333 290.750 -5,01 15,41 -236.211 4.479.120
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38.333 38.333 -50,00
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38.333 306.083 14,32
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 40.000 40.000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 82.000 82.000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -36.400 267.750 -11,97 15,02 -546.622 4.020.829
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise 91.000 0 -100,00
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise -91.000 304.150 -23,03
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8.449 0 -100,00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6.615 0 -100,00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8.449 213.150 4,13 4,19 35.401 893.098
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 6.615 204.701 3,34 4,05 26.791 829.039
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16.500 16.500 -50,00
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.551 8.449 -83,10
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -18.385 6.615 -73,54
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -76.436 119.882 -38,93 15,12 -1.155.781 1.812.724
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 16.500 196.318 9,18 3,90 64.350 765.640
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 41.551 179.818 30,05 4,19 174.099 753.437
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 18.385 138.267 15,34 4,05 74.459 559.981
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)